Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

Area of Science:

• Immunology
• Nanotechnology
• Oncology

Background:

• Immunotherapy combined with radiotherapy shows promise for cancer treatment by improving immune responses and potentially eliciting the abscopal effect.
• However, current combination strategies suffer from low response rates, necessitating improved approaches.

Purpose of the Study:

• To develop and evaluate an improved cancer immunotherapy strategy using antigen-capturing nanoparticles (AC-NPs).
• To assess the efficacy of AC-NPs in enhancing anti-programmed cell death 1 (αPD-1) therapy in a preclinical melanoma model.

Main Methods:

• Engineered various AC-NP formulations, analyzing antigen capture based on NP surface properties.
• Administered AC-NPs to deliver tumor-specific proteins to antigen-presenting cells (APCs).
• Evaluated treatment efficacy using the B16F10 melanoma model and analyzed immune cell populations (CD8+ cytotoxic T cells, CD4+ T cells, regulatory T cells).

Main Results:

• AC-NP formulation determined the specific protein antigens captured.
• AC-NPs successfully delivered tumor antigens to APCs, significantly enhancing αPD-1 immunotherapy efficacy.
• Achieved up to a 20% cure rate in the B16F10 melanoma model, compared to 0% without AC-NPs.
• AC-NPs promoted CD8+ cytotoxic T cell expansion and increased CD4+/Treg and CD8+/Treg ratios.

Conclusions:

• AC-NPs represent a novel nanotechnology strategy to improve cancer immunotherapy.
• This approach enhances the efficacy of αPD-1 treatment by optimizing antigen presentation and T cell responses.
• AC-NPs hold potential for developing more effective cancer immunotherapies.